Skip to content

Glenmark Pharma launches drug for diabetic patients with comorbidities

The Mumbai-based drug maker said it has become the first company to launch Teneligliptin (20mg) Dapagliflozin (5mg/10mg) fixed-dose combination for the treatment of adult patients with type 2 diabetes.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish